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Two paradigms for the evaluation of surrogate markers in randomized clinical trials have been proposed: the causal
effects (CE) paradigm and the causal association (CA) paradigm [1]. Each of these paradigms rely on assumptions
that must be made in order to proceed with estimation and to validate a candidate surrogate marker (S) for the true
outcome of interest (T ). We consider the setting in which S and T are Gaussian and are generated from structural
models that include an unobserved confounder. Under the assumed structural models, we relate the quantities
used to evaluate surrogacy within both the CE and CA frameworks. We review some of the common assumptions
made in order to aid in estimating these quantities and show that assumptions made within one framework can
imply strong assumptions within the alternative framework. We demonstrate that there is a similarity, but not
exact correspondence between the quantities used to evaluate surrogacy within each framework and show that
the conditions for identifiability of the surrogacy parameters are different from the conditions which lead to a
correspondence of these quantities. Copyright c© 2016 John Wiley & Sons, Ltd.
Keywords: Causal association; Direct effects; Principal stratification; Surrogate markers; Unmeasured
confounders
1. Introduction
The validation of an intermediate marker (S) as a surrogate marker for the true outcome of interest (T ) in clinical trials
has attracted much attention [2-4]. An intermediate marker shown to be a valid surrogate would allow trials to be run more
cheaply and quickly by basing analyses on the earlier or more cheaply measured surrogate. To use an example we will
refer to throughout this paper, in a clinical trial assessing the efficacy of a new therapy on lengthening overall survival
(OS) time in ovarian cancer, the duration of the trial could be reduced if the treatment effect on progression free survival
(PFS) time could be used to infer a treatment effect on OS time. However, in practice demonstrating the validity of a
surrogate marker has proven challenging, possibly due to the disease process affecting T through pathways not mediated
through the surrogate, or due to unobserved confounders, U , of S and T [5]. For instance, suppose PFS time (S) is being
assessed as a surrogate marker for OS time (T ) in ovarian cancer patients in a trial with a binary treatment (Z), where
Z = 0 is standard of care and Z = 1 is a new treatment. If patients experiencing longer PFS are also more likely to eat a
healthy diet (U ) which is also associated with longer OS, a treatment that prolonged PFS would also appear to prolong
OS, indicating PFS as a potentially valid surrogate marker even though the survival benefit was not due to the induced
treatment effect on PFS.
Several causal frameworks have been explored to identify intermediate markers as valid surrogates. Joffe and Greene
[1] group these frameworks into two paradigms. The first, termed the “causal-effects” (CE) paradigm, attempts to separate
the direct effect of the treatment (Z) on T from the effect of Z on T that is mediated through S. The second paradigm,
termed the “causal-association” (CA) paradigm, focuses on the association of the treatment effect on the surrogate and the
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treatment effect on the true endpoint. VanderWeele [6] argued that conceptually the CA paradigm is more appealing when
assessing surrogacy, although that may not be universally accepted. Each of the approaches to surrogacy assessment rely
on certain assumptions that one must be willing to make in order to proceed with estimation and the evaluation of S as a
surrogate. Ten Have and Joffe [7] and Ensor et al. [8] provide a comprehensive reviews of the estimation methods used
and the assumptions made within both the CE and CA paradigms. Here, we explore the connections between some of
the typical assumptions made within each paradigm, and examine the implications of these assumptions on the quantities
used to determine the validity of S as a surrogate marker within each of the CE and CA paradigms.
The consideration of surrogacy from a causal perspective has some similarities to causal considerations of compliance
and mediation, which can both be considered as intermediate variables between an intervention or exposure and an
outcome. A number of the assumptions we consider originate in the compliance and mediation literature [7, 9-12].
The CE paradigm can be represented as a structural model in which one can explicitly change the values of Z or S
or both, and the model specifies how the outcome T would then change. The indirect effect of Z on T is then the part
of the effect of Z that is explained by changes in S holding Z constant, and the direct effect is the part of the effect of
Z on T when the value of S is held constant. If S is a good surrogate for T , the direct effect of Z on T should be zero
for all values of S. The Prentice [2] criteria for assessing surrogacy can be considered to be in the CE paradigm. These
criteria require that S and T be correlated, that S be affected by Z, and that T and Z be conditionally independent given
S. If the coefficient of Z is zero in the regression model for T |Z, S, then S would be considered a valid surrogate. Since
this model conditions on the post randomization variable S, it will in general not have a causal interpretation. For the
Prentice criteria to be valid from a causal perspective requires the assumption of no unmeasured confounders of S and T .
This assumption is often unlikely to hold in the surrogate marker setting, where S and T are frequently involved in the
same disease process. In general, the parameters in the CE paradigm are not estimable without assumptions, of which no
unmeasured confounders is an example. In the PFS and OS example in ovarian cancer, this would preclude the possibility
of a healthy diet affecting both PFS and OS. Assumptions weaker than no unmeasured confounders have been suggested
in the literature, and these will be considered below.
The assessment of surrogacy within the CA paradigm includes methods based on principal stratification [13], which
consider the distribution of the potential outcomes of T conditional on principal strata based on the values of the potential
outcomes of S. In this framework, each subject has two potential outcomes (in the case of a binary treatment), one
under Z = 0 and one under Z = 1, for each of the surrogate and the final outcome. Measures of surrogacy are derived
from the distribution of the potential outcomes of T conditional on principal strata based on the potential values of the
outcomes of S. S is considered to be a valid principal surrogate if there is no expected treatment effect on T within the
principal stratum where there is no treatment effect on S. As the potential outcomes of S are pre-randomization variables,
they can be regarded as baseline covariates, thereby avoiding the issue of potential unobserved confounding between
the post randomization observed values of S and T . However, as only two of the four potential outcomes of S and T
are observed for each person, assumptions must be made to aid in the estimation of unidentifiable parameters. Common
assumptions often involve restrictions or assumptions on certain model parameters through the use of prior distributional
assumptions [14], or conditional independence assumptions between certain counterfactual outcomes [15-17] or concepts
of monotonicity, under which negative effects of the treatment on the surrogate marker or outcome are precluded [18]. For
the ovarian cancer example, the potential outcomes for S are the two PFS times that would have arisen under each of the
treatment arms, and the potential outcomes for T are the two OS times that would have arisen under the two treatments.
The CE paradigm additionally requires consideration of what the OS time would be if the PFS time could be externally
manipulated. While it is hard to specify how that could be achieved, it is never the less part of the conceptual framework
of the CE paradigm.
The CE paradigm is consistent with a mechanistic view of causality as it describes how the output will change if the
inputs are separately manipulated. By allowing the manipulation of S for fixed values of Z, this framework represents
a larger, more general model. By considering the potential outcomes of S and T under each treatment arm, the CA
framework does not require manipulations of S, as it is concerned with how the causal treatment effect on S is associated
with the causal treatment effect on T and not with the effect of S on T . Pearl [19] invited a discussion on the uses and
limitations of estimating effects using potential outcomes. A common argument against the use of potential outcomes and
the principal stratification approach is the unidentifiability of the principal strata. It is argued that this lack of identifiability
makes it difficult to make progress in estimation within this framework. However, estimation methods within the CE
framework also rely on untestable assumptions and on conceiving of interventions on S, which may not always be possible
[6, 20].
In this paper, in order to illustrate the connections between the CE and CA frameworks, we consider the setting in
which S and T are Gaussian. While the relationship between the CE and CA frameworks has been considered previously
in a general setting [1, 21], restricting to the Gaussian setting facilitates consideration of a larger number of different
assumptions and also allows algebraic development, providing a more clear and concrete understanding of the relationship
between these two frameworks. We assume that S and T are generated from structural models that include an unobserved
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confounder. This model is detailed in Section 2. In Section 3, we explore the relationship between the parameters of
the assumed Gaussian structural model and the model parameters in the principal surrogacy framework, and relate the
structural model parameters to the parameters used to evaluate surrogacy within both the CE and CA frameworks. In
Section 4, we briefly explore the role of baseline covariates in aiding in parameter estimation and in surrogacy evaluation.
In Section 5, we review some of the common assumptions made within the CE framework to achieve identifiability and
consider the impact of these assumptions on the parameters and quantities used to evaluate surrogacy in the CA framework.
Section 6 explores some of the assumptions used to aid in estimation within the CA framework and their impact on the
parameters within the CE framework. Section 7 presents a numerical study of the correspondence between the metrics
of surrogacy under the various assumptions described in sections 5 and 6. Section 8 briefly outlines estimation methods
for the parameters that are typically made in the two frameworks and explores how the explicit expressions derived for
the relationship between the parameters and identifying assumptions of the two frameworks could aid in the estimation of
surrogacy evaluation quantities. We conclude with a discussion in Section 9.
2. The structural model
Throughout the paper we will assume that the truth is a fairly general structural model, which is a model within the CE
framework. We assume that both the surrogate marker S and the true endpoint T are continuous. We assume that the
observed Si is generated from a structural model which depends on the treatment, Zi (Zi = 0 or 1), and on an unobserved
confounder, Ui, for each subject i, i = 1, ..., n. The observed value of Ti is also generated from a structural model that
depends on Zi, Ui and on Si. Figure 1 provides a graphical representation of the assumed model.
We use the potential outcomes framework, and assume no interference, i.e. the potential outcomes of individual i are
unaffected by the treatment and surrogate value of all other individuals. The assumed structural models for Si and Ti are
given by:
Si(Zi) = α0 + α1Zi + α2Ui + α3UiZi + e
Si(Zi) (1)
Ti(Zi, s) = β0 + β1Zi + β2s+ β3Ui + β4sZi + β5UiZi + e
Ti(Zi) (2)
where Ui ∼ N(0, 1), eSi(0) ∼ N(0, δ2S0), eSi(1) ∼ N(0, δ2S1), eTi(0) ∼ N(0, δ2T0), eTi(1) ∼ N(0, δ2T1) and Ui, eSi(0), eSi(1),
eTi(0), eTi(1) are all uncorrelated. Note that the model is quite general in the sense that it does allow the outcome to depend
on interactions between Z and U and between Z and S. To preclude having non Gaussian error terms, the model for
Ti(Zi, Si) does not include any interactions between Ui and Si. Additionally, while the error associated with the potential
outcome of Ti(Zi, Si) changes with Z, there is no additional measurement error associated with S beyond that induced by
the error of the selected S(z), only a location shift for T (Z, S(z)) conditional on eS(z). Also note that the model does not
include any other baseline covariates except for the intervention, which we assume to be randomly assigned. The situation
with baseline covariates will be discussed later.
From the structural model we have the following for the four potential outcomes:
Si(0) = α0 + α2Ui + e
Si(0)
Si(1) = α0 + α1 + (α2 + α3)Ui + e
Si(1)
Ti(0) = Ti(0, Si(0)) = β0 + β2α0 + (β2α2 + β3)Ui + β2e
Si(0) + eTi(0)
Ti(1) = Ti(1, Si(1)) =
β0 + β1 + (β2 + β4)(α0 + α1) + [(β2 + β4)(α2 + α3) + (β3 + β5)]Ui + (β2 + β4)e
Si(1) + eTi(1)
In addition to no interference, the structural model (2) assumes consistency, Ti = Ti(z, s) if Zi = z, Si = s, which
allows the observed outcome to be related to the potential outcome; and positivity, P (Zi = z | Ui = u) > 0, P (Si(z) = s |
Zi = z, Ui = u) > 0 for all z, u ∈ U , and s ∈ S. This implies that all treatments can be observed at all levels of potential
confounders and that all levels of the surrogate marker are observable at all levels of potential confounders for all levels
of treatment. The first part of the positivity assumption is trivially satisfied in the setting of a randomized trial.
The structural model described above has 14 parameters, which is the same number of parameters as the principal
surrogacy model described in the following section. For the data that can be collected in a randomized trial, under the
assumption that S and T are Gaussian, there are ten estimable quantities corresponding to the means and variances of S(0),
S(1), T (0) and T (1) and the correlations of (S(0), T (0)) and (S(1), T (1)). While the structural model is a mechanistic
model, the parameters still cannot all be estimated without untestable assumptions. Similarly, in the principal surrogacy
model, there are ten estimable parameters; in the following section, we explicitly link the parameters of these two models.
When there are no unmeasured confounders in the structural model, (i.e. α2 = α3 = 0 or β3 = β5 = 0 or both), then all
of the remaining parameters of this model are identifiable, as are the parameters of the principal surrogacy framework. In
Sections 4 and 5, we explore some of the common assumptions made within the CE and CA frameworks and the impact
of these assumptions on the quantities used to evaluate S as a surrogate marker.
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3. The CA and CE frameworks
3.1. The causal association model
The CA paradigm of surrogacy evaluation includes methods based on the “principal surrogacy” framework of Frangakis
and Rubin [13]. This framework focuses on the distribution of the potential outcomes of T conditional on principal
strata defined by the values of the potential outcomes of S. Let Si(z) and Ti(z) denote the potential outcomes
of Si and Ti, respectively, for subject i under treatment assignment Zi = z. We assume the joint distribution of
(Si(0), Si(1), Ti(0), Ti(1)) is multivariate normal [14] with mean µ and covariance matrix Σ, and has the following
distribution:
Si(0)Si(1)Ti(0)
Ti(1)
 ∼ N

µS0µS1µT0
µT1
 ,

σ2S0 ρsσS0σS1 ρ00σS0σT0 ρ01σS0σT1
σ2S1 ρ10σS1σT0 ρ11σS1σT1
σ2T0 ρtσT1σT0
σ2T1

 (3)
The mean µ and the variances corresponding to the diagonal elements of Σ, as well as the correlation parameters ρ00 and
ρ11 are fully identifiable from the observed data. However, because only one of the counterfactual pairs of outcomes is
observed for each subject, the correlation parameters ρs, ρ01, ρ10, and ρt are not identifiable from data. The parameters
of the structural model detailed in Section 2 can be directly related to the principal surrogacy model when the joint
distribution of the potential outcomes of S and T is multivariate normal. The formulas for all the µs, σs and ρs in terms of
the αs, βs and δs are given in Appendix A.
While there is a direct mapping of the 14 parameters of the structural model to the 14 parameters of the principal
surrogacy model, there is not an explicit formula to map the parameters of the principal surrogacy model back to the
structural model parameters. For some combinations of parameters within the parameter space of the principal surrogacy
model no parameter combinations within the parameter space of the structural model exist.
3.1.1. Measures of surrogacy. To evaluate S as a surrogate marker within the principal surrogacy framework, Gilbert
and Hudgens [15] proposed two properties that a good surrogate should possess, “average causal necessity” (ACN)
and “average causal sufficiency” (ACS). ACN requires that there be no conditional treatment effect on T within the
principal stratum where there is no treatment effect on S, while ACS requires a non-zero conditional treatment effect
on T within principal strata where there is a non-zero treatment effect on S. For the ovarian cancer trial example with
PFS as a potential surrogate for OS, ACN would be met if patients who would experience the same PFS under either
treatment arm would on average experience the same OS under either treatment. ACS would be met if patients who
would experience greater PFS in one treatment arm would on average experience greater OS under this treatment arm.
The primary quantities of interest from the multivariate normal model used to evaluate surrogacy can be derived from
the conditional distribution of (T (1)− T (0) | S(1)− S(0) = s), which in the joint Gaussian setting is normal with mean
given by E[T (1)− T (0)|S(1)− S(0) = s] = γ0 + γ1s, where:
γ0 = (µT1 − µT0)−
(
ρ11σS1σT1 − ρ10σS1σT0 − ρ01σS0σT1 + ρ00σS0σT0
σ2S0 + σ
2
S1
− 2ρsσS0σS1
)
(µS1 − µS0) (4)
γ1 =
(
ρ11σS1σT1 − ρ10σS1σT0 − ρ01σS0σT1 + ρ00σS0σT0
σ2S0 + σ
2
S1
− 2ρsσS0σS1
)
. (5)
ACN is then satisfied if γ0 = 0 and ACS is satisfied if γ1 6= 0. We note that neither γ0 nor γ1 depend on ρt, however, the
variance of [T (1)− T (0)|S(1)− S(0) = s] does depend on ρt.
Based on the mapping of the parameters, the surrogacy quantities of interest in the CA framework γ0 and γ1 can be
rewritten as:
γ0 = β1 + β4(α0 + α1)− α1
(
β4(α
2
3 + α3α2 + δ
2
S1) + β5α3
δ2S0 + δ
2
S1 + α
2
3
)
(6)
and
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γ1 = β2 +
β4(α
2
3 + α3α2 + δ
2
S1) + β5α3
δ2S0 + δ
2
S1 + α
2
3
. (7)
The principal surrogacy criteria requiring that γ0 = 0 and γ1 6= 0 will be met if β1 + β4(α0 + α1) =
α1
(
β4(α
2
3+α2α3+δ
2
S0)+β5α3
δ2S0+δ
2
S1+α
2
3
)
and these quantities are greater than −β2α1 for γ1 > 0 and less than −β2α1 for γ1 < 0.
Thus the requirements of the structural model within the CE framework for achieving principal surrogacy under the CA
framework are not simple.
3.2. The causal effects model
3.2.1. Direct and indirect effects. The causal effects framework for surrogacy evaluation attempts to quantify the direct
effect of Z on T , and the indirect effect of Z on T that is mediated through S. The notions of direct and indirect effects
[22, 23] are defined by the counterfactual outcomes Si(z) and Ti(z, s), where Si(z) is the value of S for subject i under
treatment assignment Zi = z and Ti(z, s) is the counterfactual outcome of T for subject i when Zi is set to z and Si is set
to s. Robins and Greenland [22] and Pearl [23] provide definitions of the natural direct effect (NDE(z)), natural indirect
effect (NIE(z)) and total effect (TE). The NDE(z) measures the effect of Z on T when S is set to its potential value
under treatment assignment z. The NIE(z) measures the effect on T when Z is set to z and S is changed to what it would
have been if Z were set to 1 compared to what it would have been if Z were set to 0. Finally, the TE of Z on T is equal to
the sum of the NIE(1) and NDE(0) or to the sum of NIE(0) and NDE(1). Imai, Keele and Yamamoto [11] focus on
the average causal effects of NDE(z), NIE(z) and TE defined by E[NDE(z)], E[NIE(z)], E[TE] respectively. From
the assumed structural model, these average causal effects are given in Table 1. The average causal effects correspond
to the relevant component parameters in the structural model. For example, E[NDE(0)] equals the direct effects of Z
on T plus the effect of Z on S brought through the interaction between S and Z on T . Since U ∼ N(0, 1), the expected
effects in Table 1 do not depend on the parameters associated with the unmeasured confounders. An additional notion
to measure the direct effect of Z on T is the controlled direct effect [22, 23]. It measures the effect of a treatment
on an outcome after intervening to fix the value of the surrogate S to the same value s for the whole population; in
the context of the ovarian cancer example, this would correspond to an intervention that sets the PFS time to be equal
across the population before estimating the treatment effect on OS. In terms of the counterfactuals, we can define it as
CDE = E[T (1, s)− T (0, s)] = β1 + β4s.
Note that if there is no interaction between the surrogate and the treatment in the structural model, then theCDE and the
NDE coincide. However, the total effects decomposes into the sum of the NDE and the NIE, but such decomposition
is not available when using the CDE, so we shall not consider the CDE any further in this paper.
3.2.2. Measures of surrogacy. A measure of surrogacy in the CE framework is the ratio of the indirect effect to the total
effect, denoted by PE(Z), which can also be interpreted as the proportion of treatment effect on T explained by S. From
the assumed structural model, PE(z) is given by:
PE(0) =
E[T (0, S(1))− T (0, S(0))]
E[T (1, S(1))− T (0, S(0))] =
α1β2
β1 + β2α1 + β4(α0 + α1)
(8)
and
PE(1) =
E[T (1, S(1))− T (1, S(0))]
E[T (1, S(1))− T (0, S(0))] =
α1(β2 + β4)
β1 + β2α1 + β4(α0 + α1)
. (9)
For S to be considered a perfect surrogate marker, E[NDE(z)] should be zero and E[NIE(z)] should be non-zero,
indicating that all of the effect of Z on T is mediated through S. The PE(z) provides a measure of the proportion of
treatment effect on T that is explained by S, and should be large for good surrogate markers and equal to one for a perfect
surrogate. In the ovarian cancer example, an E[NDE(z)] of zero would imply that the treatment only effects OS time
through its effect on PFS time and a non-zero E[NIE(z)] would be the effect on OS time due to the treatment effect
induced on PFS time, net of any treatment effect.
3.2.3. Relationship to Prentice criteria. Special cases of the direct and indirect effects approach to determine surrogacy
are the Prentice [2] criteria and the closely related mediation methods proposed by Baron and Kenny [9]. The Prentice
criteria considers the regression model
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E[T |S,Z] = θ0 + θ1Z + θ2S + θ3SZ,
and S is considered a perfect surrogate if θ1 = θ3 = 0. From the structural model it can be shown that,
θ1 = β1 − β3 δ
2
S0(α1+α0)(α2+α3)+α
2
2(α2α1+α1α3−α0α3)−α0α2(α23+δ2S1)
(α22+δ
2
S0)((α2+α3)
2+δ2S1)
− β5 (α1+α0)(α2+α3)(α2+α3)2+δ2S1
and
θ3 = β4 − β3 α
2
2α3+α2(α
2
3+δ
2
S1)−δ2S0(α2+α3)
((α2+α3)2+δ2S1)(α
2
2+δ
2
S0)
+ β5
(α2+α3)
(α2+α3)2+δ2S1
.
The coefficients of the Prentice model (θ0, θ1, θ2, θ3) depend on the coefficients of the confounding variables in
equations 1 and 2 (i.e. they depend on α2, α3, β3, β5). Therefore, for the assessment of surrogacy using the Prentice
criteria to be a valid causal assessment of surrogacy, there must be no confounders of S (α2 = α3 = 0) or no confounders
of T (β3 = β5 = 0) so that we have θ1 = β1 and θ3 = β4. In the absence of confounders, S will be considered a perfect
surrogate marker for T based on the Prentice criteria if α1 6= 0, β2 6= 0, β1 = 0 and β4 = 0 and subsequently θ1 = θ3 = 0.
In this case, the direct effect of Z on T will be zero and all of the treatment effect will be completely mediated through
S. The methods of Baron and Kenny [9] also require no unobserved confounders and additionally require there to be no
interaction of Z and S (β4 = 0). Then, if α1 and β2 are non-zero, α1β2 can be interpreted as the mediation effect, or the
effect of Z that is explained by S.
In the absence of unobserved confounders and no interaction effect of S and Z, Freedman, Graubard, and Schatzkin
[3] proposed a quantity to measure the proportion of treatment effect explained by S, derived from the ratio of treatment
effects estimated from two regression models for T , one with no adjustment for S and the other adjusting for S. Freedman’s
proportion explained is one minus this ratio, given by p = 1− β1β1+α1β2 , where p = 1 corresponds to a perfect surrogate.
Wang and Taylor [24] proposed an estimate of the proportion of treatment effect explained by S that can be estimated
from the observed data in the presence of an interaction of S and Z. For the structural model assumed here, this quantity
is equivalent to PE(z) in equations 8 and 9.
3.3. Correspondence between the CA and CE models
Within the CE framework, S will be considered a valid surrogate when the natural direct effects are zero, corresponding
to β1 = 0 and β4 = 0 and the natural indirect effects are non-zero (α1 and β2 are non-zero). Within the CA framework,
S is considered a valid surrogate if γ0 = 0 and γ1 6= 0. VanderWeele [21] referred to the expected treatment effect on
T within principal strata where there is no treatment effect on S, here corresponding to γ0, as the “principal strata
direct effect” and the expected treatment effect on T within principal strata where there is a treatment effect on S, here
corresponding to γ1, as the “principal strata indirect effect”. Working at the individual level, VanderWeele [21] showed
that when the natural direct effects are zero for all subjects, corresponding to the assumption β1 = β4 = β5 = 0 and
δ2S0 = δ
2
S1 = δ
2
T0 = δ
2
T1 = 0, there is no principal strata direct effect, corresponding to γ0 = 0, therefore meeting the CA
surrogacy criteria. In our case, where we are interested in the expected natural direct effects, which are zero when β1 = 0
and β4 = 0, the surrogacy quantities of the CA model will be γ0 = − α1β5α3δ2S0+δ2S1+α23 and γ1 = β2 +
β5α3
δ2S0+δ
2
S1+α
2
3
when the
expected natural direct effects are zero. Therefore, when the criteria for surrogacy are met within the CE framework, the
criteria within the CA framework will not always be satisfied, but will be met if either α3 = 0 or β5 = 0, i.e. if either of
the UiZi interactions in Equation 1 or Equation 2 are zero.
When there is no interaction effect between S and Z on T (β4 = 0), and no interaction between the unmeasured
confounder U and Z for either the outcome (β5 = 0) or the surrogate marker (α3 = 0), then there is a simple relationship
between the proportion explained (PE(z)) measure in the CE framework and the ACN and ACS parameters γ0 and
γ1 in the CA framework. In particular, β4 = 0 implies NDE(0) = NDE(1) = NDE = β1, α3 = 0 implies E(s) =
E(S(1))− E(S(0)) = α1, while β4 = 0 and β5 = 0 together imply that γ0 = β1 and γ1 = β2. Thus
PE(0) = PE(1) = PE = 1− NDE
TE
=
γ1E(s)
γ0 + γ1E(s)
= 1− γ0
γ0 + γ1E(s)
.
Thus γ0 can only be treated as analogous to the direct effect in the CE framework if there is no interaction effect of S
and Z on T and there is no treatment interaction with the unobserved confounder on either the outcome or the surrogate
marker.
3.3.1. Simulation experiments. The above algebra showed that the metrics of surrogacy in the CE framework (NDE(Z),
NIE(Z) and PE(Z)) do not correspond to the metrics of surrogacy in the CA framework (γ0 and γ1) unless special
conditions are met. To further understand the magnitude of the differences between the parameters and measures of
surrogacy in the CE model and the CA model, we undertook a simulation experiment. We simulated a broad range
of reasonable parameter combinations in the structural model. Additionally, the average total effect (β1 + β2α1 +
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β4(α0 + α1)) was constrained to be positive. Drawing the CE parameters in this way ensured that α1 > 0, β2 > 0 and
(β2 + β4) > 0, which is a reasonable assumption in the surrogate marker setting where any S being considered as a
potential surrogate for T would be known to have an association with the treatment and with T . Additionally, under the
distributional assumptions, the magnitude of the coefficients of the confounding variable on S and on T must be less than
the magnitude of the coefficient of α1 and β2, respectively, and δ2S0 and δ
2
S1 are constrained to have the same values, as
are δ2T0 and δ
2
T1. Restricting the average total effect to be greater than zero ensures that PE(z) is greater than zero. For
each parameter set, we calculated the corresponding parameters in the CA model and also the measures of surrogacy in
both frameworks. Details of the distributions used to generate parameters for the simulations are provided in Appendix B.
The range of R2 values for regression models of T |Z, T |S and T |U is also shown in Appendix B, and demonstrates that
the way in which the parameters were simulated was not overly restrictive and leads to a wide spectrum of scenarios. We
explored the sensitivity of the simulation results to the chosen distributions and found that the results appear generalizable
to parameters arising from different distributions.
Figure 2 provides scatter plots of the correlation parameters of the CA model for the simulated CE model parameters.
The plots show that ρs, ρt, ρ00 and ρ11 are almost always positive, that ρ00 and ρ11 are generally larger than the other
four correlation parameters and that ρs and ρt are generally larger than ρ01 and ρ10. Figure 3 provides a scatter plot of
E[NDE(0)] versus γ0. We see that there is a close correspondence between the direct effects and γ0. Figure 4 provides
plots of γ0 vs. γ1 for different values of PE. When PE is small, γ0 tends to be greater than zero. As PE increases, the
distribution of γ0 becomes more centered around zero. The plots show that although there is not a perfect concordance
between the surrogacy measures in the two frameworks, similar conclusions regarding the validity of S as a surrogate
marker will often be drawn from the two frameworks.
The above figures represent the degree of agreement between the two concepts of surrogacy, as if the joint distribution
of all the counterfactual outcomes were known, that is all the parameters in Equations 1 and 2 were known. In practice the
parameters would have to be estimated from observed data.
4. Baseline Covariates
In many settings, observed baseline covariates (X) are available that may explain some of the dependence between S
and T , and explain some of the effect of Z on S and T . Often baseline covariates are sought that will control for any
confounding of S and T . If X is a binary or categorical covariate, the models and assumptions within both the CE and CA
frameworks could be made within strata defined by X . If X is a continuous covariate or a continuous linear combination
of covariates, additional parameters could be added to the structural model to give:
Si(Zi) = α0 + α1Zi + α2Ui + α3UiZi + ψ1Xi + ψ2XiZi + e
Si(Zi)
Ti(Zi, Si) = β0 + β1Zi + β2Si + β3Ui + β4SiZi + β5UiZi + ω1Xi + ω2XiZi + e
Ti(Zi).
This model now has 18 parameters to estimate and leads to a new CA model given by:
Si(0)Si(1)Ti(0)
Ti(1)
 ∼
N

 µS0 + ψ1XiµS1 + (ψ1 + ψ2)XiµT0 + ω1Xi
µT1 + (ω1 + ω2)Xi
 ,

σ2S0 ρsσS0σS1 ρ00σS0σT0 ρ01σS0σT1
σ2S1 ρ10σS1σT0 ρ11σS1σT1
σ2T0 ρtσT1σT0
σ2T1

. The mean parameters of this model are
estimable and, as the covariance matrix does not change with the addition of baseline covariates, there are still four
correlation parameters that are not estimable. Full development of the structural model given in Equations 1 and 2
can be assumed to be conditional on X , making the common assumptions of conditional independence and sequential
ignorability discussed in the next section more plausible. In Appendix D we describe the consequence of including
additional covariates on the natural direct and indirect effects, on the Prentice criteria and on γ0 and γ1.
5. Assumptions made within the CE framework
The structural model assumed in Section 2 is not identifiable from the observed data. Therefore, assumptions must be made
in order to aid in the estimation of the parameters and identification of the direct and indirect effects. We review some of the
common identifying assumptions made within the CE framework and explore the implications of these assumptions on the
parameters of the principal surrogacy model. The no interference assumption is expanded to mean that the treatment level
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of one individual has no effect on the surrogate of another, and we require generalized consistency, namely S(z) = S,
and T (z, S(z)) = T when Z = z.
5.1. No unmeasured confounders
A critical assumption to identification within the causal effects framework is that there are no unobserved confounders
driving the association between the outcome and the treatment or between the surrogate marker and the outcome. In the
ovarian cancer example, the assumption of no unobserved confounders between the outcome and the treatment will be
met because it is a randomized clinical trial. The assumption of no unobserved confounders between the surrogate marker
and the outcome precludes the possibility that diet affects both PFS time and OS time, and therefore would only be a
reasonable assumption to make in this context if diet was not thought to be associated with both of these outcomes, or
if covariate information was available to be included in the model to sufficiently control for this association. Different
versions of the no unmeasured confounders assumption are made in the literature.
Let X denote a set of measured covariates. Pearl [23] required conditional exchangeability, meaning that conditional
on measured covariates X , treatment Z is “random”, and that once we stratify according to Z and X , their level of S is
also essentially random. More formally,
Ti(z) ⊥ Z | Xi = x
Ti(z
′, s) ⊥ Si(z) | Zi = z,Xi = x
for all z, z′ and x ∈ X , implying no Z − T confounding conditionally on observed covariates X , and no S − T
confounding conditionally on observed covariates X and Z. The first assumption is automatically satisfied in randomized
trials.
The conditional exchangeability assumption is replaced by Imai, Keele, and Yamamoto [11] by sequential ignorability,
defined as
Ti(z
′, s), Si(z) ⊥ Zi | Xi = x
Ti(z
′, s) ⊥ Si(z) | Zi = z,Xi = x
for all z, z′ and x ∈ X . Again, the first assumption is automatically satisfied in randomized trials; the second is stronger,
especially in the setting we have here without covariates.
Under our assumption of randomized treatment, Pearl and Imai, Keele, and Yamamoto correspond. Under the structural
model (2) without covariates, sequential ignorability implies Pearl’s conditions for identification.
Petersen, Sinsi, and van der Laan [25] replace the assumption Ti(z′, s), Si(z) ⊥ Zi | Xi = x of Imai, Keele, and
Yamamoto with the weaker assumption that the outcome rather than the joint distribution of the surrogate and the outcomes
is independent of treatment: Ti(z′, s) ⊥ Zi | Xi = x, but require the additional assumption that the magnitude of the direct
effect is independent of the potential values of the surrogate marker conditional on observed covariates:
ES(z) [Yi(1, s)− Yi(0, s) | Si(z) = s,X = x] = ES(z) [Yi(1, s)− Yi(0, s) | X = x] .
As with the assumptions of Pearl [23], the Petersen, Sinsi, and van der Laan requirements match those of sequential
ignorability in a randomized trial setting.
While these identification assumptions hold without further parametric assumptions, we can translate them into our
parametric structural model by noting
Si(0) = α0 + α2Ui + e
S(0)
i
Si(1) = α0 + α1 + (α2 + α3)Ui + e
S(0)
i
Ti(0, s) = β0 + β2s+ β3Ui + e
T (0)
i
Ti(1, s) = β0 + (β2 + β4)s+ (β3 + β5)Ui + e
T (0)
i .
The requirement that Ti(z′, s) ⊥ Si(z) | Zi = z,Xi = x implies α2 = 0 or β3 = 0 when Z = 0, and α2 + α3 = 0 or
β3 + β5 = 0 when Z = 1, or, more concisely, α2 = α3 = 0 or β3 = β5 = 0, so that either S(Zi) or T (Zi, Si) is
independent of Ui and thus Ui no longer confounds the surrograte marker and the outcome.
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5.2. No interaction
Recent work by VanderWeele [26] has highlighted the important role of interactions in mediation analysis. Baron
and Kenny [9] propose methods for mediation analysis based on solving a system of linear equations. In order to
obtain causal interpretations of the parameters of their models, an assumption of no unmeasured confounders as well
as no interaction is necessary. This leads to the structural model of Section 2 with α2 = α3 = 0 or β3 = β5 = 0 and
β4 = 0. Then, E[NDE(0)] = E[NDE(1)] = β1, E[NIE(1)] = E[NIE(0)] = α1β2 and E[TE] = β1 + β2α1. Under
these assumptions we have ρs = ρ01 = ρ10 = ρt = 0, and if δ2S0 = δ
2
S1 and δ
2
T0 = δ
2
T1 then ρ00 = ρ11. For our data
example in ovarian cancer, these assumptions imply that diet does not affect both PFS time and OS time and OS time
changes with PFS time to the same degree under both treatment arms. This assumption may therefore be reasonable
to make if there is clinical knowledge to support the notion that longer (shorter) PFS times will result in similarly
longer (shorter) OS times, regardless of treatment given. Under these assumptions, γ0 is equal to the natural direct effect
(E[NDE(0)] = E[NDE(1)] = γ0 = β1) and γ1 = β2, leading to exact correspondence between the CE and CA measures
of surrogacy. Therefore, if β1 = 0 and β2 6= 0, S will be a valid surrogate for T from both the CE or CA model perspective.
5.3. Conditional independence assumption
Daniels et al. [12] work under the assumption of conditional independence between potential outcomes which assumes that
T (1, S(1)), T (1, S(0)) and T (0, S(0)) are conditionally independent given S(0) and S(1). In the ovarian cancer example,
this assumption implies that given two PFS times, s0 and s1, under Z = 0 and Z = 1, respectively, amongst the set of
people who have potential outcomes s0 and s1, the OS times under Z = 0 and the OS times under Z = 1 are independent,
and also independent of the OS time under Z = 1 for PFS time s0. They note that this assumption is not necessary to
estimate the direct and indirect effects, however, in their Bayesian estimation strategy for estimating NDE and NIE,
these assumptions are needed to estimate features of the posterior distribution of these quantities, such as the posterior
variance. The conditional covariances of these three outcomes from the structural model of Section 2 are as follows:
Cov[T (0, S(0)) , T (1, S(1)) | S(0), S(1)] = β3(β3+β5)δ
2
S0
δ2S1
δ2S0
(α2+α3)2+δ2S1
(α22+δ
2
S0
)
,
Cov[T (0, S(0)) , T (1, S(0)) | S(0), S(1)] = β3(β3+β5)δ
2
S0
δ2S1
δ2S0
(α2+α3)2+δ2S1
(α22+δ
2
S0
)
, and
Cov[T (1, S(1)) , T (1, S(0)) | S(0), S(1)] = δ
2
S0
δ2S1
(β3+β5)
2+δ2S0
δ2T1
(α2+α3)
2+δ2S1
δ2T1
(α22+δ
2
S0
)
δ2S0
(α2+α3)2+δ2S1
(α22+δ
2
S0
)
In order for the three conditional independence assumptions to hold, in the structural model we must have (β3 + β5) = 0
and the possibly unrealistic assumption that δ2T1 = 0, making this assumption difficult to satisfy in most scenarios. In
terms of the parameters of the causal association model, this assumption does not change the correlation parameters ρs,
ρ00 and ρ10, and only slightly alters ρt, ρ11 and ρ01. The surrogacy quantities of interest, γ0 and γ1, are unchanged by this
assumption.
5.4. Exclusion restriction
Many of the assumptions discussed so far required no unobserved confounding. The instrumental variable approach does
not make assumptions about S–T confounding, but instead assumes that all of the effect of Z on the outcome is mediated
by the intermediate variable Si, i.e. that the direct effect of Z is zero, i.e. Ti(1, s) = Ti(0, s). This assumption is called
exclusion restriction. More specifically, in the setting where the intermediate variable is binary (e.g. binary mediator
or binary indicator of compliance to treatment), the exclusion restriction assumption requires that the distribution of
the potential outcomes of T be independent of treatment assignment in the principal strata defined by the potential
intermediate variable. So for the never-takers, (Si(0) = Si(1) = 0), and the always-takers (Si(0) = Si(1) = 1), this
implies Ti(1, s) = Ti(0, s) = β0 + β2s+ β3Ui [31], and thus β1 = β4 = β5 = 0. In the continuous setting, Holland [32]
and Sobel [33] have a similar requirement for identifiability, requiring that β1 + β4s+ β5U = 0. While in the compliance
literature, it is often reasonable to assume that the treatment has no direct effect on the outcome, we note that the exclusion
restriction is not compatible with the goals of surrogacy evaluation, as it assumes that the direct effect of treatment on the
outcome is zero, which in turn assumes that S is a valid surrogate marker [7], and would therefore never be a reasonable
assumption to make in this setting.
6. Assumptions made within the CA framework
As in the CE setting, some parameters of the principal surrogacy model are unidentifiable from the data, requiring
assumptions to be made to aid in estimation. The assumptions that are typically made vary based on the setting being
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explored and on the quantities of interest. In some settings, baseline covariate information is available that can aid in
estimating the missing potential outcomes of S, or a “constant biomarker” assumption can be made about the potential
outcomes of S in the control arm [15, 27]. Outside of these settings, assumptions must be placed on certain model
parameters or on certain relationships between potential outcomes in order to proceed with estimation. While there is
not a one-to-one mapping of the principal surrogacy model parameters to the structural model parameters as there is
from the structural model parameters to the principal surrogacy model parameters, the assumptions made in the principal
surrogacy setting have implicit effects on the parameters of the structural model.
6.1. Prior assumptions on correlation parameters
Within the setting of multivariate normally distributed outcomes of S(0), S(1), T (0), and T (1), Conlon, Taylor and Elliott
[14] used a Bayesian estimation strategy and placed different plausible prior assumptions on the unidentified correlation
parameters. These assumptions, along with the positive definite restriction of the covariance matrix aided in estimation.
The assumptions made include restricting the correlation parameters to be positive and a restriction with respect to the
ordering of the magnitudes of the correlations. These assumptions are reasonable in many surrogate marker settings,
where the surrogate marker and the final outcome are often part of the same disease process. In the context of the ovarian
cancer example, it would be reasonable to assume that the correlation parameters are positive, especially if the observed
correlations between PFS time and OS time within each treatment arm are positive. It may also be reasonable to assume
that the correlation between PFS time and OS time within the same treatment arm, the correlation between PFS times
across treatment arms and the correlation between OS times across treatment arms are larger than the correlations between
PFS time and OS time in opposite treatment arms. The implications of these assumptions on the parameters of the CE
model are explored below.
6.1.1. Positivity of correlations. One assumption made by Conlon, Taylor and Elliott [14] restricts all of the correlation
parameters to be positive. This assumption is motivated by the fact that S and T are usually scientifically or biologically
related, and therefore if a person has an inherent frailty then this will result in both S and T being higher (or lower)
irrespective of the treatment that they receive. In terms of the structural model, if we assume that (β2 + β4) ≥ 0, which
would be expected in any setting where S is being considered as a potential surrogate marker, restricting the correlation
parameters to be positive requires one of the following two settings: (1) α2 > 0, (α2 + α3) > 0, (β2α2 + β3) > 0 and
(β3 + β5) + (β2 + β4)(α2 + α3) > 0 or (2) α2 < 0, (α2 + α3) < 0, (β2α2 + β3) < 0 and (β3 + β5) + (β2 + β4)(α2 +
α3) < 0. These settings imply that the effect of U must act in the same direction on both S and T . In our ovarian cancer
data example, this implies that healthy diets are associated with both longer PFS time and longer OS time and would not
be associated with a longer PFS time combined with a shorter OS time or vice versa. Figure 3 provides scatter plots from
the simulation experiment of the correlation parameters of the CA model for the simulated CE model parameters. The
scatter plots show that under the assumed structural model, all six of the correlations are greater than zero a majority of
the time, with ρ00 and ρ11 nearly always positive and ρs and ρt usually positive, indicating that the positivity assumption,
at least for ρs, ρt, ρ00 and ρ11, would be reasonable in this setting.
6.1.2. Ordering of correlations. Another assumption explored by Conlon, Taylor and Elliott [14] restricts all of the
correlation parameters to be positive and also restricts ρ10 and ρ01 to be less than the other four correlation parameters.
This constraint is reasonable as ρ10 and ρ01 are measures of the correlation between S and T in opposite treatment arms,
which is unlikely to be larger than the correlation between the S and T within the same treatment arm, or the correlation
between the surrogate responses or final treatment responses across treatment arms. As not all combinations of parameter
values of the principal surrogacy model are possible under the assumed structural model, it can be shown that one such
set of parameters arises under the restriction of positivity and ordering of the correlations. If only the assumption about
the ordering of the correlations is imposed and positivity is not assumed, then one of the following two settings is implied
in terms of the structural model: (1) α2 > 0, (α2 + α3) > 0, (β2α2 + β3) < 0, and (β2 + β4)(α2 + α3) + (β3 + β5) < 0
or (2) α2 < 0, (α2 + α3) < 0, (β2α2 + β3) > 0, and (β2 + β4)(α2 + α3) + (β3 + β5) > 0. These settings imply that the
effect of U on S must be in the same direction for Z = 0 and Z = 1 and the effect of U on T must be in the opposite
direction as that of U on S, but the effect of U on T must be in the same direction for Z = 0 and Z = 1. In terms of the
ovarian cancer example, this would imply that patients with healthy diets have longer (shorter) PFS time, regardless of
their treatment assignment, but shorter (longer) OS time in either treatment arm. The scatter plots in Figure 3 show that
under the assumed structural model, the assumption that ρ00 and ρ11 are greater than ρ10 and ρ01 appears to hold nearly all
the time, and the assumption that ρs is greater than ρ10 and ρ01 holds the majority of the time. However, the assumption
that ρt is greater than ρ10 and ρ01 holds only about half of the time
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6.2. Conditional independence assumptions
Another approach to estimation in this framework involves reducing the number of unidentified parameters that must
be estimated through assumptions about conditional independences. One common conditional independence assumption
that has been considered is that of conditional independence of T (0) and T (1) given S(0) and S(1) [15, 16, 28, 29].
This assumption reduces the number of unidentified parameters by one, as ρt becomes a function of the other five
correlation parameters. Specifically, this implies that ρt =
ρ11ρ10+ρ01ρ00−ρs(ρ01ρ10+ρ11ρ00)
(1−ρ2s) . In terms of the structural model,
conditional independence of T (0, S(0)) and T (1, S(1)) given S(0) and S(1) implies that β3(β3 + β5) = 0. Therefore, in
order for this conditional independence assumption to hold we must have either β3 = 0 or (β3 + β5) = 0, i.e. there is zero
effect of the unmeasured confounder in one of the treatment arms on the outcome T . This would imply in the ovarian
cancer trial example that patients with healthy diets have similar OS times to those with unhealthy diets in at least one of
the treatment arms, and would therefore only be reasonable to make if diet is not thought to be associated with both OS
time and PFS time.
A different conditional independence assumption was made by Parast, McDermott and Tian [17] who assumed S(0)
and T (1) were conditionally independent given S(1) and that S(1) and T (0) were conditionally independent given S(0),
implying in the ovarian cancer example that given knowledge of PFS time under one treatment arm, OS time in the
same treatment arm and PFS in the opposite treatment arm are independent. The consequence of these assumptions is the
following
ρ01
ρ11
=
ρ10
ρ00
= ρs.
The consequence if this, derived from the equations in Appendix C, requires α2 = α3 = β2 = β4 = 0 and also holds
for selected other parameter combinations.
A similar, but weaker, conditional independence assumption [30] is that S(0) and T (1) were conditionally independent
given S(1) and T (0) and that S(1) and T (0) were conditionally independent given S(0) and T (1), implying in the ovarian
cancer example that given knowledge of both PFS time under one treatment arm and OS time in the opposite treatment arm,
OS time and PFS in the other treatment arms are independent. The consequence of these assumptions are the following:
assuming S(0) ⊥ T (1)|S(1), T (0) gives
ρSρ11 − ρ00ρ10ρ11 + ρT ρ00 − ρSρT ρ10
ρ01(1− ρ210)
=
σ2S0σ
2
T1
σ2S1σ
2
T0
and assuming S(1) ⊥ T (0)|S(0), T (1) gives
ρSρ00 − ρ11ρ01ρ00 + ρT ρ11 − ρSρT ρ01
ρ10(1− ρ201)
=
σ2S1σ
2
T0
σ2S0σ
2
T1
6.3. Monotonicity assumption
Within the setting of a binary surrogate and final outcome, Li, Taylor and Elliott [18] impose a monotonicity
assumption to aid in the problem of non-identifiability. Specifically, they require that Si(1) ≥ Si(0) and Ti(1) ≥ Ti(0)
for all i. In terms of the structural model, this requires that α1 + α3Ui + eSi(1) ≥ eSi(0) and β1 + β4(α0 + α1) + β2α1 +
[β4(α2 + α3) + β2α3 + β5]Ui + (β2 + β4)e
Si(1) + eTi(1) ≥ β2eSi(0) + eTi(0), which cannot be satisfied with Gaussian random
variables. If monotonicity is only required to hold in expectation so that E[Si(1)] ≥ E[Si(0)] and E[Ti(1)] ≥ E[Ti(0)]
, this reduces to α1 ≥ 0 and β1 + β4(α0 + α1) + β2α1 ≥ 0. As α1 and β2 are assumed to be positive within the surrogate
marker setting, this assumption will hold as long as the average total effect of Z on T is positive. In the ovarian cancer
setting, this holds if on average the combined effect of treatment and PFS time in the Z = 1 arm on OS time is greater
than this combined effect on OS time in the Z = 0 arm, and would be reasonable to assume in this scenario for a treatment
thought to improve OS time, as PFS time is known to be positively associated with the OS time.
7. Numerical study of impact of assumptions on correspondence between the CE and CA metrics
of surrogacy
The assumptions described in the previous sections are made either because they are reasonable in the scientific context or
because they aid in estimation of quantities of interest. In this section we evaluate whether making these assumptions also
leads to closer correspondence between the metrics of surrogacy in the two frameworks. Using the simulation experiment
described in Section 3.3.1, we plot the distribution of γ0 and of γ1 when |γ0| ≤ 0.25 for different ranges of PE(0). We
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note that the conditional independence assumption made by Daniels et al. [12] is not included, as the condition cannot be
met under the parameter distributions used in our simulations. In the simulation experiment, for each assumption we only
retain the draws of the parameters that either exactly or approximately satisfy the assumption.
7.1. Ordering of correlations assumption in CA framework
Under the assumption of Section 5.1.2 that ρs, ρt, ρ00 and ρ11 are all positive and that ρ01 < min(ρs, ρt, ρ00, ρ11) and
ρ10 < min(ρs, ρt, ρ00, ρ11) the boxplots in Figure 5(b) show that the correspondence between the measures of surrogacy
in the CE and CA frameworks is slightly improved as compared to the model without parameter restrictions (boxplot
shown in Figure 5(a)). There is an increase in concordance between γ0 and PE(0), with γ0 decreasing as PE(0) increases.
7.2. Conditional independence assumptions in CA framework
The first conditional independence assumption of Section 5.2 is that T (0) and T (1) are independent given (S(0), S(1)).
The second conditional independence assumption of Section 5.2 is that T (0) and S(1) are independent given S(0) and
that T (1) and S(0) are independent given S(1) and the third conditional independence assumption of Section 5.2 is that
T (1) and S(0) are independent given S(1) and that T (0) and S(1) independent given S(0).
Under the first two assumptions, the boxplots in Figures 5(c) and 5(d) show that the relationship between γ0 and PE(0)
is brought into slightly higher concordance by making these assumptions. In our simulations there were no cases where
|γ0| ≤ 0.25 when PE(0)= 0.25, indicating that when S is a poor surrogate, the CA framework and the CE framework
would always agree. However, the relationship between γ1 and PE(0) is in somewhat less concordance compared to
the model with no parameter restrictions, with very little increase in γ1 as PE(0) increases. Under the third conditional
independence assumption, the boxplots in Figures 5(e) also show an increased concordance between the CE and CA
measures of surrogacy, with γ1 increasing as PE(0) increases but with slightly less concordance of γ0 and PE(0) as
compared to the first and second conditional independence assumptions.
7.3. Sequential ignorability assumptions in CE framework
Under the assumption of Section 4.1 that α2 = α3 = 0 or β3 = β5 = 0 the boxplots in Figure 6(b) and Figure 6(c) show
some increase in the concordance between γ0 and PE(0), with γ0 larger when PE(0) is small and moving toward 0 as
PE(0) increases, but little additional concordance between γ1 and PE(0) is achieved by making this assumption.
7.4. Sequential ignorability and no interaction assumptions in CE framework
The sequential ignorability assumption of Section 4.3 together with the no interaction assumption of Section 4.4 is (i)
β4 = 0 and (ii) α2 = α3 = 0 or β3 = β5 = 0. For the combined sequential ignorability and no interaction assumption,
the boxplot in Figure 6(d) shows a similar relationship between the CE and CA measures of surrogacy as with the
sequential ignorability assumption alone, with some increase in the concordance between γ0 and PE(0), but little additional
concordance of γ1 with PE(0) as compared to the model with no parameter restrictions.
8. Estimation and Sensitivity Analyses
8.1. Estimation
In the CA framework, the approach to estimation of the parameters in the multivariate normal model (Equation 3) is
relatively straightforward. Either equality types of assumptions are made to make the model identifiable and likelihood
based methods are used, or inequality types of constraints can be expressed in the form of prior distributions and a
Bayesian approach can be taken using MCMC methods. From the estimates, inference about γ0 and γ1 is easy either from
the delta method or directly from the MCMC draws. The Bayesian approach for not fully identified models is not without
its challenges [34], especially if non-informative or only very weakly informative priors are used. In our experience
[18], MCMC algorithms can be slow to converge, and from a frequentist perspective the coverage rates of 95% credible
intervals can deviate from the desired level. In the CE framework, estimation of the direct and indirect effects derived from
the parameters in Equations 1 and 2 usually proceeds by making identifying assumptions, such as sequential ignorability,
and then non-parametrically estimating the direct and indirect effects [7,11,35,36].
Since the parameters in the CA framework are a direct function of the parameters in the CE framework, a different
approach to estimation of γ0 and γ1 is to undertake estimation of the CE parameters in Equations 1 and 2 using a
Bayesian approach, making assumptions that are appropriate for the context, and then mapping these directly to the
CA parameters to obtain γ0 and γ1. It may even be possible to make reasonable, but not strong assumptions in both
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frameworks simultaneously using prior distributions, and then undertake Bayesian estimation to obtain inference for
γ0 and γ1. For example, one might assume approximate sequential ignorability (as in Section 4.2) and approximate
conditional independence (as in Section 5.2) and make inequality assumptions (as in Section 5.1).
8.2. Sensitivity Analyses
The estimation methods presented here for the CE approach assume no unobserved confounding. In the context of a
randomized treatment, as is the case here, this assumption translates to “no unobserved confounding” of the surrogate-
outcome relationship. Many sensitivity analyses to this unobserved confounding have been proposed, but the strategy to
follow will depend on whether there is an interaction between the treatment and the surrogate and the type of the outcome
(i.e. continuous or binary). In the absence of a treatment-surrogate interaction, the NDE and the CDE coincide, and thus
simpler sensitivity analysis techniques, which are available for the CDE, can be employed. VanderWeele [37] develops an
approach for binary confounders that computes bias in the CDE as the product of the expected difference in the outcome
at the two levels of the confounder conditional on treatment and the expected difference in the confounder at the two levels
of treatment. Imai et al. [11] propose a sensitivity analysis that fits more closely with the structural model proposed here,
by introducing a correlation between the error terms in the structural equations for T and S. Beginning with equations
analogous to Equations (1) and (2), we have,
Si = α0 + α1Zi + ψ1Xi + eS (10)
Ti = β0 + β1Zi + β2s+ ω1Xi + β4sZi + eT (11)
Where X1 is a measured baseline confounder and allow for the error terms eS and eT to be correlated. The correlation
between these error terms, ρ, thus becomes the sensitivity parameter that the user must specify. Imai et al. [11] then
give expressions for the NDE and the NIE in terms of the correlation term, and other parameters that can be estimated
from the observed data. This method works for both continuous and binary outcomes, and has been implemented in the
command medsens, as part of the R software package mediation. In the context of Equations (1) and (2), if we assume
no confounder treatment interaction then the correlation between eS and eT is proportional to α2β3. Thus a sensitivity
analysis could consist of estimation with this product held fixed.
An alternative approach within the CE framework, not yet attempted to our knowledge, would be to study the sensitivity
to departures from the identification assumptions by using prior distributions with small variances. For example, instead
of sequential ignorability assumption 1 in Table 2 that α2 = α3 = 0 or β3 = β5 = 0 set α2 ∼ N(0, σ2α2), α3 ∼ N(0, σ2α3)
and β3 ∼ N(0, σ2β3), β5 ∼ N(0, σ2β5) where σ2α2 , σ2α3 , σ2β3 and σ2β5 are all small. For other parameters less informative
priors would be used. Then proceed with Bayesian estimation.
9. Discussion
Within the setting of Gaussian surrogate and final outcome variables, we have explored the connection between the
quantities used to evaluate surrogacy within the CE framework of surrogacy assessment and the CA framework of
surrogacy assessment. Under the assumed structural models for S and T , there is a direct mapping of the 14 parameters
of these models to the 14 parameters of a Gaussian principal stratification model. Not all of these 14 parameters
can be identified from the observed data alone, and therefore assumptions must be made in order to proceed with
estimation. We have reviewed some of the common assumptions made within the CE and the CA frameworks, and
explored the consequences of these assumptions on model parameters and quantities used to determine surrogacy. With
parameter values from the assumed structural model that are reasonable in the surrogate marker setting, there is a close
correspondence between the natural direct effect and average causal necessity. Under the assumptions of Baron and Kenny
[9] of no interaction (β4 = 0) and no unobserved confounding (α2 = α3 = 0 or β3 = β5 = 0) the surrogacy evaluation
quantities in the CE and CA framework are equivalent, with E[NDE(0)] = E[NDE(1)] = γ0 = β1. This equivalence
also holds under slightly weaker conditions of β4 = 0 and either α3 = 0 or β5 = 0, however these conditions do not lead
to identifiability. With the exception of the assumptions made by Baron and Kenny [9], the assumptions made within
the CE or the CA framework that aid in estimation do not aid in bringing the surrogacy evaluation quantities in closer
alignment.
Most estimation methods within the CE framework rely on assumptions about the absence of post-treatment unobserved
confounders of S and T . This assumption is untestable and may be unlikely to hold in the surrogate marker setting, where
S and T are usually involved in the same disease process. In contrast, the CA framework does not require assumptions
about the absence of post-treatment confounders, as it focuses on the potential outcomes of S, which can be treated as
baseline covariates. However, due to unobserved potential outcomes, assumptions must be made to aid in the estimation
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of unidentified parameters. If baseline covariate information is available, this may aid in the estimation of the unobserved
principal strata of S. Baseline covariate information can also be used within the CE framework to relax assumptions about
post-treatment confounding. However, estimation methods in this case require the presence of a baseline covariate that
has an interaction effect with Z on S [1, 38], and we have shown in Appendix C that when such interactions exist, S will
not be a valid surrogate within the CA framework.
The CE and CA frameworks have tradeoffs in terms of assumptions, bias in parameter estimation and variability [39].
Estimation methods within the CA framework have been shown to have less bias, but more variability than standard
methods within the CE framework [40]. As the parameters of the proposed structural model have a direct mapping to the
parameters of the CA model, these models offer the potential for assumptions that are reasonable to make in one framework
to aid in informing the parameter values within the alternative framework. In this way, both the CE and CA models could
be employed with reasonable, but not especially strong assumptions made in the evaluation of S as a surrogate marker.
While the research in this paper has focused on the situation of surrogate markers, the frameworks of CA and CE have
also been considered in mediation analysis. It would be of interest to evaluate the correspondence between the metrics of
mediation in this setting too. We have focused on Gaussian variables and linear models and have shown a certain degree
of correspondence for evaluating the surrogates, and the degree of correspondence increasing if certain assumptions are
made. For non-Gaussian variables we hypothesize we might expect broadly similar findings, but with possibly a lower
degree of correspondence, due to the nonlinear link functions in the models.
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A. Relationship of CE and CA model parameters
The parameters of the principal surrogacy model (Equation 3) relate to those of the assumed structural model (Equations
1 and 2) assuming U ∼ N(0, 1) in the following way:
µS0 = α0
µS1 = α0 + α1
µT0 = β0 + β2α0
µT1 = β0 + β1 + (β2 + β4)(α0 + α1)
σ2S0 = α
2
2 + δ
2
S0
σ2S1 = (α2 + α3)
2 + δ2S1
σ2T0 = (β2α2 + β3)
2 + β22δ
2
S0 + δ
2
T0
σ2T1 = [(β2 + β4)(α2 + α3) + (β3 + β5)]
2
+ (β2 + β4)
2δ2S1 + δ
2
T1
ρs =
α2(α2+α3)√
α22+δ
2
S0
√
(α2+α3)2+δ2S1
ρ00 =
α2(β2α2+β3)+β2δ
2
S0√
α22+δ
2
S0
√
(β2α2+β3)2+β22δ
2
S0+δ
2
T0
ρ01 =
α2[(β2+β4)(α2+α3)+(β3+β5)]√
α22+δ
2
S0
√
[(β2+β4)(α2+α3)+(β3+β5)]
2+(β2+β4)2δ2S1+δ
2
T1
ρ10 =
(α2+α3)(β2α2+β3)√
(α2+α3)2+δ2S1
√
(β2α2+β3)2+β22δ
2
S0+δ
2
T0
ρ11 =
(α2+α3)[(β2+β4)(α2+α3)+(β3+β5)]+(β2+β4)δ
2
S1√
(α2+α3)2+δ2S1
√
[(β2+β4)(α2+α3)+(β3+β5)]
2+(β2+β4)2δ2S1+δ
2
T1
ρt =
(β2α2+β3)[(β2+β4)(α2+α3)+(β3+β5)]√
(β2α2+β3)2+β22δ
2
S0+δ
2
T0
√
[(β2+β4)(α2+α3)+(β3+β5)]
2+(β2+β4)2δ2S1+δ
2
T1
.
B. Parameter distributions and R2 values for regression models of T |Z, T |S and T |U from
simulation experiment
For the simulation experiment, the CE model parameters were generated such that
α0, β0 = 0,
α1 ∼ U(0.25, 1.5),
α2 ∼ U(max(−0.5,min(−α1 + 0.05, α1 − 0.05)),max(−α1 + 0.05, α1 − 0.05)),
α3 ∼ U(min(−α2/2, α2/2),max(−α2/2, α2/2)),
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β1 ∼ U(−0.3, 1.5),
β2 ∼ U(0.1, 1.5),
β3 ∼ U(max(−0.5,min(−β2 + 0.05, β2 − 0.05)),max(−β2 + 0.05, β2 − 0.05)),
β4 ∼ U(min(−β2/3, β2/3),max(−β2/3, β2/3)),
β5 ∼ U(min(−β3/2, β3/2),max(−β3/2, β3/2)),
δ2S0, δ
2
T0 ∼ U(0.3, 1),
δ2S1 = δ
2
S0,
δ2T1 = δ
2
T0.
Figure B.1 below provides boxplots of the R2 values across all of the parameter draws for regression models of T |Z,
T |S and T |U , where S and T are 10,000 random samples from each set of parameter draws. The plots show that the
simulated parameters lead to a broad range of R2 values, indicating that the way in which the parameters were simulated
was not overly restrictive and leads to a wide spectrum of scenarios.
Figure B.1. Proportion of variance of T explained by Z, S and U for a range of plausible values from the assumed structural model.
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C. Consequence of conditional independence assumptions in the CA framework on parameters in
the CE model
In terms of the structural model, the assumptions that S(0) and T (1) are conditionally independent given S(1) and that
S(1) and T (0) are conditionally independent given S(0) requires the following
(β2α2+β3)(α2+α3)(α
2
2+δ
2
S0)−α22(α2+α3)2−(α2(β2α2+β3)+β2δ2S0)2
α22+δ
2
S0
=
α2[(β2+β4)(α2+α3)+(β3+β5)]((α2+α3)
2+δ2S1)−α22(α2+α3)2−([(β2+β4)(α2+α3)+(β3+β5)](α2+α3)+(β2+β4)δ2S1)2
(α2+α3)2+δ2S1
= 0.
D. Baseline covariates
Under the structural model with covariates, the direct and indirect effects of the CE framework become:
E[NDE(0)|X = x] = β1 + α0β4 + (β4ψ1 + ω2)x, E[NDE(1)|X = x] = β1 + β4(α0 + α1) + (β4(ψ1 + ψ2) + ω2)x,
E[NIE(0)|X = x] = β2(α1 + ψ2x), E[NIE(1)|X = x] = (β2 + β4)(α1 + ψ2x), and E[TE|X = x] = (β2 + β4)α1 +
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α0β4 + β1 + ((β2 + β4)ψ2 + β4ψ1 + ω2)x. If there is no interaction effect of X and Z on S (ψ2 = 0), then the indirect
effect will not be changed by the presence of baseline covariates. Under the assumption of sequential ignorability,
estimates of the direct and indirect effects in the presence of a baseline covariate can be obtained non-parametrically by
integrating over the distribution of X . The Prentice model in the presence of baseline confounders becomes: E[T |S,Z] =
θ0 + θ1Z + θ2S + θ3SZ + θ4X + θ5XZ, where θ1 and θ3 are as in Section 3.2 and θ4 = ω1 −
(
α2(β2α2+β3)+β2δ
2
S0
α22+δ
2
S0
)
ψ1
and θ5 = ω2 +
(
α2(β2α2+β3)+β2δ
2
S0
α22+δ
2
S0
)
ψ1 −
(
(α2+α3)[(β2+β4)(α2+α3)+(β3+β5)]+(β2+β4)δ
2
S1
(α2+α3)2+δ2S1
)
(ψ1 + ψ2). Therefore, if there
are no unmeasured confounders, the Prentice criteria will be a valid measure of surrogacy (θ1 = θ3 = θ5 = 0)
if there is no interaction effect of X and Z on either S or T (ω2 = ψ2 = 0) and additionally if either ψ1 or
β4 is zero. In this case, the baseline covariate information aids in estimation and does not affect the ability
to determine surrogacy. Under certain conditions, it is possible to relax the sequential ignorability assumption
when baseline covariates are available. For example, when sequential ignorability cannot be assumed and
baseline covariates are available for which E[S(1) | X]− E[S(0) | X] varies with X (i.e. ψ2 6= 0), and there is
no interaction effect of either Z and S on T or of Z and X on T (i.e. β4 = ω2 = 0), Joffe and Greene [1]
showed that a two-stage least squares procedure can be used to estimate the direct and indirect effects. Ten
Have et al. [38] estimate the direct and indirect effects under the same conditions as Joffe and Greene [1] by
assuming the following rank preserving model for T : T (z, s) = g(x) + γZz + γSs+  and using a G-estimation
procedure. Within the CA framework, if baseline covariates are present, the surrogacy quantities of interest become:
E[T (1)− T (0)|S(1)− S(0) = s,X = x] = (µT1 − µT0)−
(
ρ11σS1σT1−ρ10σS1σT0−ρ01σS0σT1+ρ00σS0σT0
σ2S0
+σ2S1
−2ρsσS0σS1
)
(µS1 − µS0)+(
ρ11σS1σT1−ρ10σS1σT0−ρ01σS0σT1+ρ00σS0σT0
σ2S0
+σ2S1
−2ρsσS0σS1
)
s+
(
ω2 −
(
ρ11σS1σT1−ρ10σS1σT0−ρ01σS0σT1+ρ00σS0σT0
σ2S0
+σ2S1
−2ρsσS0σS1
)
ψ2
)
x =
γ0 + γ1s+
(
ω2 −
(
ρ11σS1σT1−ρ10σS1σT0−ρ01σS0σT1+ρ00σS0σT0
σ2S0
+σ2S1
−2ρsσS0σS1
)
ψ2
)
x. When there is no interaction of X and Z on
either S or T (ψ2 = ω2 = 0), neither γ0 nor γ1 are affected by the presence of baseline covariates. In this case,
controlling for X is helpful in explaining some of the variance of the potential outcomes and does not affect
the ability to estimate γ0 or γ1. When there is an interaction of X and Z on either S or T , γ1 is not affected
but γ0 becomes a function of x: γ0 = (µT1 − µT0)−
(
ρ11σS1σT1−ρ10σS1σT0−ρ01σS0σT1+ρ00σS0σT0
σ2S0
+σ2S1
−2ρsσS0σS1
)
(µS1 − µS0)+(
ω2 −
(
ρ11σS1σT1−ρ10σS1σT0−ρ01σS0σT1+ρ00σS0σT0
σ2S0
+σ2S1
−2ρsσS0σS1
)
ψ2
)
x. In this case, when there is no treatment effect on S, the
expected treatment effect on T depends on the baseline covariate, implying that S may only be a valid principal
surrogate for T within certain subgroups defined by X . In order for ACN to be met and S to be considered a valid
principal surrogate, we would need to have γ0 = 0 for all X , requiring
∫
x
E[T (1)− T (0) | S(1)− S(0) = 0, X =
x]f(X | S(1)− S(0) = 0)dx be equal to zero, which is unlikely to hold. Therefore, in order for S to be considered a
valid principal surrogate, there can be no interaction of the baseline covariate X with Z, so that both ψ2 and ω2 are equal
to zero. In the CA framework, baseline covariates have also been used to aid in estimating the principal strata of S. For
example, a model for f(S(1) | X,Z = 1) can be estimated using the surrogate response values in the Z = 1 arm and a
model for f(S(0) | X,Z = 0) can be estimated using the surrogate response values in the Z = 0 arm. These models can
then be used to impute missing S(1) values in patients in the Z = 0 arm and missing S(0) values in patients in the Z = 1
arm, respectively [15,16]. Implicit in this assumption is that [S(1) | X,S(0)] = [S(1) | X], requiring that ρs = 0, i.e. that
either α2 = 0 or α2 + α3 = 0.
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Table 1. Expressions for direct, indirect and average causal effects
E[NDE(0)]: E[T (1, S(0))− T (0, S(0))] = β1 + α0β4
E[NDE(1)]: E[T (1, S(1))− T (0, S(1))] = β1 + β4(α0 + α1)
E[NIE(0)]: E[T (0, S(1))− T (0, S(0))] = α1β2
E[NIE(1)]: E[T (1, S(1))− T (1, S(0))] = α1(β2 + β4)
E[TE]: E[T (1, S(1))− T (0, S(0))] = β1 + β2α1 + β4(α0 + α1)
Table 2. Consequence of the sequential ignorability and no interaction assumptions on parameters within the CA
framework.
Assumption
1. α2 = α3 = 0 2. β3 = β5 = 0
No unmeasured confounders for S No unmeasured confounders for T
ρs 0
α2(α2+α3)√
(α22+δ
2
S0)((α2+α3)
2+δ2S1)
ρ00
β2δ
2
S0√
δ2S0(β
2
3+β
2
2δ
2
S0+δ
2
T0)
β2(α
2
2+δ
2
S0)√
(α22+δ
2
S0)((β2α2)
2+β22δ
2
S0+δ
2
T0)
ρ01 0
α2(β2+β4)(α2+α3)√
(α22+δ
2
S0)([(β2+β4)(α2+α3)]
2+(β2+β4)2δ2S1+δ
2
T1)
ρ10 0
(α2+α3)β2α2√
((α2+α3)2+δ2S1)((β2α2)
2+β22δ
2
S0+δ
2
T0)
ρ11
(β2+β4)δ
2
S1√
δ2S1((β3+β5)
2+(β2+β4)2δ2S1+δ
2
T1)
(β2+β4)((α2+α3)
2+δ2S1)√
((α2+α3)2+δ2S1)([(β2+β4)(α2+α3)]
2+(β2+β4)2δ2S1+δ
2
T1)
ρt
β3(β3+β5)√
(β23+β
2
2δ
2
S0+δ
2
T0)((β3+β5)
2+(β2+β4)2δ2S1+δ
2
T1)
β2α2(β2+β4)(α2+α3)√
((β2α2)2+β22δ
2
S0+δ
2
T0)([(β2+β4)(α2+α3)]
2+(β2+β4)2δ2S1+δ
2
T1)
γ0 (β1 + β4(α0 + α1))− α1β4
(
δ2S1
δ2S0+δ
2
S1
)
(β1 + β4(α0 + α1))− α1β4
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Figure 1. Causal graph for the intervention (Z), the surrogate (S) and the final outcome (T ) with an unmeasured confounder (U ).
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Figure 2. CA model parameters for a range of plausible values from the assumed structural model.
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Figure 3. Correspondence between NDE and γ0 for a range of plausible values from the assumed structural model.
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Figure 4. Correspondence between CA surrogacy measures (γ0 and γ1) and CE surrogacy measures (PE(0)) for a range of plausible values from the assumed structural model.
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Figure 5. Correspondence between CA surrogacy measures (γ0 and γ1 shown on vertical axis) and CE surrogacy measure (PE(0) shown on horizontal axis) under assumptions
made in the CA framework
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Figure 6. Correspondence between CA surrogacy measures (γ0 and γ1) and CE surrogacy measure (PE(0)) under assumptions made in the CE framework
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